Market Overview

Onychomycosis | A Drug Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest drug pipeline analysis report on onychomycosis.
The report includes a detailed analysis of the pipeline molecules under
investigation within the defined data collection period to treat

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for onychomycosis, including a ...

Technavio has published a new report on the drug development pipeline for onychomycosis, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Onychomycosis: Market overview

A fungal infection caused in the nails is called as onychomycosis. It is
also known as Tinea unguium. Onychomycosis is a broad term and
does not only include disease caused due to dermatophytes but also
includes infections caused due to yeasts and saprophytic molds. The
symptoms of onychomycosis include discoloration, flaking, and
thickening. Onychomycosis can be treated with medication either oral or
topical and applying nail lacquers to protect the nail plates of
fingernails and toenails.

According to a senior market research analyst at Technavio, "There
are three types of onychomycosis, which include distal and lateral
subungual onychomycosis, proximal subungual onychomycosis, white
superficial onychomycosis, and candida onychomycosis."

Onychomycosis: Segmentation analysis

This pipeline analysis report segments the onychomycosis market based on
therapies employed (monotherapy), RoA (topical, oral, subungual, and
transdermal), therapeutic modality (small molecule, and peptide),
targets (squalene epoxidase (SE), CYP51, succinate dehydrogenase, and
cell membrane), MoA (SE inhibitor, CYP51 inhibitor, succinate
dehydrogenase inhibitor, and cell membrane permeability enhancer),
geographical segmentation (US, Germany, and others) and recruitment
status (active, not recruiting, and recruiting). It provides an in-depth
analysis of the prominent factors influencing the market, including
drivers, opportunities, trends, and industry-specific challenges.

Based on the route of administration, more than 68% of the molecules
that are being investigated for the treatment of onychomycosis are
topical drugs.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!